Biography
Biography: Prashant S Agnihotri
Abstract
BRVO is a common retinal condition affecting working population and their performance. Its sudden occurrence and protracted course results in unforeseen hardship. Anti-VEGF has revolutionized the management to a large extent. Various studies have proven its efficacy to improve the retinal circulation by clearing the hge early. In our experience over last few years we have been injecting intravitreal soon after diagnosing and ruling out the contraindication for its use. The results shall be presented with serial optical coherence tomography (OCT) and rational for early use shall be discussed.